
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Detailed analysis of CVS Health's recent strategic moves, financial performance, and market positioning for informed investors.
A deep dive into CVS Health's CostVantage, gene therapy payment models, and stock volatility. Explore challenges, opportunities, and strategic implications for investors.
CVS Health navigates rising healthcare costs, expands flu services, and manages Medicare Advantage challenges. Cost-cutting and strategic adjustments are key.
CVS Health navigates market volatility, Medicare challenges, and strategic shifts in 2025. Key developments, cost measures, and analyst insights examined.
CVS Health navigates Medicare pressures, strategic shifts, and economic headwinds, impacting its financial performance and future prospects. Key challenges and opportunities analyzed.
CVS Health faces Medicare challenges, manages gene therapy costs, and navigates interest rate impacts in 2025. A comprehensive analysis of its strategic outlook.
CVS Health navigates Medicare pressures, cost-cutting, and gene therapy risks amidst market volatility. Analyst views mixed as CVS adapts to a changing healthcare landscape.
A comprehensive, data-driven analysis of CVS Health’s earnings, leadership changes, digital innovations, and market strategy.
A deep dive into CVS Health’s Q4 2024 performance, stock surge, and strategic initiatives driving its turnaround.
Explore CVS Health’s Q4 2024 earnings, leadership shifts, and strategic moves to drive a turnaround in 2025.